Innovative AI Solutions Median Technologies specializes in advanced AI-powered imaging solutions and software as medical devices that enhance early diagnosis and treatment accuracy for cancer and metabolic diseases, providing a strong value proposition for healthcare providers and biopharmaceutical companies seeking cutting-edge diagnostic tools.

Regulatory Milestones The company has achieved significant regulatory progress, including recent successful interactions with the FDA for its iBiopsy LCS CADe/CADx system, indicating readiness to expand into the U.S. market and appealing to healthcare institutions and regulators seeking validated medical imaging solutions.

Strategic Industry Engagement Active participation in major healthcare events like RSNA and ASCO demonstrates Median’s commitment to industry visibility and partnership opportunities, making it an ideal partner for organizations aiming to stay at the forefront of medical imaging innovation.

Robust Financial Profile With a revenue between $50M and $100M supported by €21.6M (US$24M) in recent funding, Median is financially equipped to scale sales efforts, invest in further R&D, and expand market presence globally in the medical imaging and diagnostics sector.

Growing Market Presence Operating in France with subsidiaries in the US and China, and being listed on Euronext Growth, Median offers localized support and global reach, making it an attractive partner for healthcare providers and biopharma companies looking for innovative imaging solutions across multiple regions.